Skip to main content
Clinical Trials/NCT05569525
NCT05569525
Active, not recruiting
Not Applicable

Effects of Non-surgical Periodontal Therapy on the Glycemic Variability of Periodontal Patients Affected by Type I Diabetes. a Randomized Clinical Trial.

University of Florence1 site in 1 country100 target enrollmentNovember 6, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 1 Diabetes
Sponsor
University of Florence
Enrollment
100
Locations
1
Primary Endpoint
Glycated hemoglobin (HbA1c)
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

Current evidence suggests a bidirectional association between periodontitis and diabetes. Periodontal therapy improves short term HbA1c levels and is safe to perform. Most studies are focused on type 2 Diabetes. Literature about the correlation between periodontitis and type 1 diabetes is scarce, since no randomized clinical trials have been performed.

The objective of the present clinical investigation is to evaluate the effects of nonsurgical treatment of periodontal disease on glycemic variability in patients with type 1 diabetes (T1DM). The hypothesis is that nonsurgical periodontal therapy affects glycemic variability in terms of time spent in hyperglycemia.

Registry
clinicaltrials.gov
Start Date
November 6, 2022
End Date
December 10, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Francesco Cairo

Prof.

University of Florence

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Type 1 diabetes
  • Patients under treatment in the department of Diabetology of AOU Careggi having a microinfusor for continuous subcutaneous insulin infusion (CSII) and a Flash Glucose Monitoring (FGM) device
  • Diagnosis of periodontitis (all stages and grades)

Exclusion Criteria

  • Contraindications for non-surgical periodontal therapy
  • Pregnancy
  • History of other systemic disease (cancer, HIV, bone metabolic dysease, Head and Neck Radiotherapy, Immunosuppressive/modulating therapy)

Outcomes

Primary Outcomes

Glycated hemoglobin (HbA1c)

Time Frame: 6 months after the non-surgical periodontal treatment

Glycated hemoglobin (HbA1c) to evaluate glycemic variability measured as a percentage (%).

Secondary Outcomes

  • Standard Deviation (SD) of glycaemia(6 months after the non-surgical periodontal treatment)
  • Glucose coefficient of variability (CV)(6 months after the non-surgical periodontal treatment)

Study Sites (1)

Loading locations...

Similar Trials